Repurposing Tamoxifen for Tumor Microenvironment Priming and Enhanced Tumor‐Targeted Drug Delivery
Ilaria Biancacci(Theranostics (New Zealand)), Twan Lammers(RWTH Aachen University), Karina Benderski(Universitätsklinikum Aachen), Alexandros Marios Sofias, Yang Shi(Guiyang College of Traditional Chinese Medicine), Fabian Kießling(Universitätsklinikum Aachen), Cristianne J.F. Rijcken(Cristal Therapeutics (Netherlands)), Mariëlle Thewissen(Cristal Therapeutics (Netherlands)), Diana Moeckel(Theranostics (New Zealand)), Leonard Kaps(Saarland University), Jeffrey Momoh(Theranostics (New Zealand)), Elena Rama(RWTH Aachen University), Robert Pohlberger(DWI – Leibniz Institute for Interactive Materials), Jai Prakash(Radboud University Nijmegen), Quim Peña(DWI – Leibniz Institute for Interactive Materials), Daniele De Santis(University of Urbino), Lorena Consolino(University of Turin)
Cited by 3
Related Papers
Tumor targeting via EPR: Strategies to enhance patient responses
|Advanced Drug Delivery Reviews|2018|1.2k
Smart cancer nanomedicine
|Nature Nanotechnology|2019|1.2k
Tumour-targeted nanomedicines: principles and practice
|British Journal of Cancer|2008|535
Core-crosslinked polymeric micelles: Principles, preparation, biomedical applications and clinical translation
|Nano Today|2015|499
Applications of nanoparticles for diagnosis and therapy of cancer
|British Journal of Radiology|2015|477